Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Statements of Operations

v3.23.3
Unaudited Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Revenue:        
Product revenue, net $ 15,279 $ 16,043 $ 44,405 $ 55,074
Other revenue 19,260 73 19,519 2,629
Total revenue 34,539 16,116 63,924 57,703
Operating expenses        
Cost of goods sold - product revenue 6,429 7,221 20,645 23,057
Research and development 2,229 2,812 6,036 6,687
Selling, general and administrative 8,636 15,575 34,069 45,481
Loss on impairment of intangible assets     3,143  
Total operating expenses 17,294 25,608 63,893 75,225
Income (loss) from operations 17,245 (9,492) 31 (17,522)
Other expense (income)        
Interest income (8) (3) (209) (10)
Interest expense 268 559 1,674 1,402
Foreign exchange transaction losses 101 22 181 22
Total other expense (income) 361 578 1,646 1,414
Income (loss) before income taxes 16,884 (10,070) (1,615) (18,936)
Income tax expense 95 10 95 50
Net income (loss) $ 16,789 $ (10,080) $ (1,710) $ (18,986)
Net income (loss) per common share:        
Basic $ 0.91 $ (0.57) $ (0.09) $ (1.09)
Diluted $ 0.80 $ (0.57) $ (0.09) $ (1.09)
Weighted average number of common shares:        
Basic 18,416,368 17,618,064 18,078,437 17,464,561
Diluted 21,034,758 17,618,064 18,078,437 17,464,561